Top 5 Stock Picks of Billionaire Nicholas Pritzker

Page 5 of 5

1. Twist Bioscience Corporation (NASDAQ:TWST

Tao Capital Stake Value: $88,659,000
Percentage of Tao Capital’s 13F Portfolio: 23.62%
Number of Hedge Fund Holders: 19

Twist Bioscience Corporation (NASDAQ:TWST), situated in South San Francisco, is a public firm that produces synthetic DNA and DNA products for various sectors. As of the third quarter, Catherine D. Wood’s ARK Investment Management is the largest Twist Bioscience Corporation (NASDAQ:TWST) stakeholder, holding 3.95 million shares worth $422.15 million.

In November, Twist Bioscience Corporation (NASDAQ:TWST) announced that it had struck a formal agreement to purchase Abveris. This privately-owned company specializes in vivo antibody discovery services for up to $190 million in cash.

A total of 19 hedge funds were bullish on Twist Bioscience Corporation (NASDAQ:TWST) at the end of the third quarter, holding stakes worth $780.11 million. This is comparable to 23 funds holding stakes valued at over $1.16 billion in the company in the previous quarter.

In its second-quarter investor letter, Baron Funds expressed confidence in Twist Bioscience Corporation (NASDAQ:TWST). Here is what the fund said:

“We initiated a position in Twist Bioscience Corporation, a provider of synthetic DNA. The company’s proprietary semiconductor-based platform has driven its position as the low-cost provider of DNA for a variety of high-growth applications. These include the attractive areas of synthetic biology, liquid biopsy, and antibody discovery. Of note, the antibody business has the potential to become a source of high-margin royalty streams in the future. As further optionality, we believe Twist has a shot at disrupting the entire digital data storage industry with DNA-based storage.”

You can also take a peek at 11 Stocks to Buy Now According to Chet Kapoor’s Tenzing Global and Top 10 Stock Picks of John Overdeck and David Siegel’s Two Sigma Advisors

Page 5 of 5